Winrevair Approved for Pulmonary Arterial Hypertension - Renal and Urology News
The FDA has approved Winrevair (sotatercept-csrk) for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1).
Source: renalandurologynews.com
Page 13 - Breakthrough Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Breakthrough Therapy Today - Breaking & Trending Today
Travere Therapeutics to Present Abstracts at the Society for Inherited Metabolic Disorders and Genetic Metabolic Dieticians International
Posters to be presented highlighting research investigating pegtibatinase as the first potential disease-modifying treatment for classical homocystinuriaSAN DIEGO, April 04, 2024 -- Travere...
Source: marketscreener.com
AstraZeneca, Daiichi make US progress with licence approvals
AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US. The Cambridge, England-based pharmaceutical company said that its Voydeya treatment had been...
Source: marketscreener.com
Mirum Pharmaceuticals LIVMARLI Receives Positive Reimbursement Recommendation by Canada s CADTH for Patients with Cholestatic Pruritusin Alagille Syndrome
FOSTER CITY - Mirum Pharmaceuticals, Inc. today announced that the Canadian Agency for Drugs and Technologies in Health Canadian Drug Expert Committee has recommended public reimbursement for...
Source: marketscreener.com
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
— NDA accepted and both fruquintinib and sintilimab granted Priority Review, following Breakthrough Therapy designation in July 2023 — — First regulatory filing for fruquintinib for use in...
Source: marketscreener.com